Is Ozempic Tirzepatide? What You Need to Know

No, Ozempic is not tirzepatide. Ozempic contains semaglutide, a GLP-1 receptor agonist, while tirzepatide is a different active ingredient that targets both GIP and GLP-1 receptors. They are separate prescription medications with different FDA approvals, dosing schedules, and clinical profiles.

Ozempic vs. Tirzepatide: The Core Difference

Ozempic (semaglutide) and tirzepatide (sold as Mounjaro and Zepbound) belong to different drug classes. Ozempic is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist.

This means tirzepatide mimics two hormones that regulate appetite and blood sugar, while Ozempic mimics one. That difference may explain why tirzepatide often produces greater average weight loss in trials.

If you are wondering is ozempic semaglutide, the answer is yes — Ozempic's active ingredient is semaglutide. Wegovy and Rybelsus also contain semaglutide but are approved for different uses.

If you're wondering is tirzepatide the same as ozempic, the short answer is no. They share some effects on appetite and blood sugar, but they are not interchangeable.

Quick Comparison Table

Feature	Ozempic (semaglutide)	Tirzepatide (Mounjaro/Zepbound)
Active ingredient	Semaglutide	Tirzepatide
Drug class	GLP-1 receptor agonist	Dual GIP/GLP-1 receptor agonist
FDA-approved for type 2 diabetes	Yes (Ozempic)	Yes (Mounjaro)
FDA-approved for weight loss	Yes (Wegovy, not Ozempic)	Yes (Zepbound)
Typical dosing	Once weekly injection	Once weekly injection
Manufacturer	Novo Nordisk	Eli Lilly

Is Tirzepatide Better Than Ozempic for Weight Loss?

Clinical trials suggest tirzepatide produces greater average weight loss than semaglutide. In the SURMOUNT-1 trial, participants on tirzepatide lost about 15–21% of their body weight over 72 weeks. In the STEP-1 trial, semaglutide 2.4 mg led to about 15% average weight loss.

• Tirzepatide 15 mg: average weight loss of about 21% in SURMOUNT-1.
• Semaglutide 2.4 mg: average weight loss of about 15% in STEP-1.
• Head-to-head: The SURPASS-2 trial in type 2 diabetes showed tirzepatide lowered A1C more than semaglutide 1 mg.

However, which drug is better depends on individual factors. Some people tolerate one medication better than the other. Your doctor can help you weigh benefits and risks.

For a deeper dive, see tirzepatide vs semaglutide which is better for weight loss. That comparison focuses on head-to-head data and real-world results.

Is Wegovy the Same as Tirzepatide?

No, Wegovy is not the same as tirzepatide. Wegovy contains semaglutide, the same active ingredient as Ozempic, but it is FDA-approved specifically for chronic weight management. Tirzepatide is a completely different molecule.

This is a common point of confusion because both Ozempic and Wegovy are semaglutide products. The difference between Ozempic and tirzepatide is larger than the difference between Ozempic and Wegovy.

If you are comparing weight-loss medications, remember that Zepbound (tirzepatide) and Wegovy (semaglutide) are both approved for obesity. Ozempic is not approved for weight loss alone.

Survodutide, Mazdutide, and Other Investigational Options

Researchers are studying several new drugs that may compete with tirzepatide. Survodutide and mazdutide are not FDA-approved for any use in the United States as of 2025.

Survodutide is a dual glucagon/GLP-1 receptor agonist. Mazdutide is a dual GLP-1/glucagon receptor agonist. Early trials show promising weight loss, but more data are needed.

Drug	Mechanism	Status
Survodutide	Glucagon/GLP-1 dual agonist	Investigational
Mazdutide	GLP-1/glucagon dual agonist	Investigational
Retatrutide	GIP/GLP-1/glucagon triple agonist	Investigational

These investigational drugs are not available by prescription in the US. Always rely on FDA-approved options and clinical guidance.

Cost, Insurance, and Compounded Versions

When comparing tirzepatide vs ozempic cost, list prices are high for both. Ozempic's list price is around $968 per month, while Mounjaro and Zepbound list for about $1,000–$1,100 per month. Insurance coverage varies widely.

• Insurance: Many plans cover Ozempic for type 2 diabetes but require prior authorization for weight loss.
• Savings cards: Manufacturers offer copay assistance for eligible patients.
• Compounded drugs: Cheaper but not FDA-approved and not recommended by regulators.

Many people ask what is the difference between semaglutide and tirzepatide compound. Compounded versions are not FDA-approved and may contain different forms or doses. The FDA has warned about risks from unapproved compounded semaglutide and tirzepatide.

If cost is a barrier, talk to your prescriber about savings programs, insurance appeals, or clinical trials. Never buy from unverified online sources.

Safety and Side Effects

Both Ozempic and tirzepatide can cause gastrointestinal side effects like nausea, vomiting, diarrhea, and constipation. These often improve over time.

• Common: nausea, vomiting, diarrhea, constipation, fatigue, headache.
• Serious: pancreatitis, gallbladder disease, kidney injury, thyroid C-cell tumors (boxed warning).
• Not for: people with a personal or family history of medullary thyroid cancer or MEN2.

Always consult a healthcare professional before starting, stopping, or switching medications. This article is for information only and is not medical advice.

COMMON QUESTIONS

Frequently Asked Questions

Is Ozempic a tirzepatide?

No. Ozempic contains semaglutide, while tirzepatide is a separate active ingredient found in Mounjaro and Zepbound. They are different drugs with different mechanisms and dosing.

Is tirzepatide better than Ozempic?

In clinical trials, tirzepatide produced greater average weight loss than semaglutide. However, individual responses vary, and some people may tolerate Ozempic better. Your doctor can help you decide which is right for you.

Is Wegovy the same as tirzepatide?

No. Wegovy is semaglutide, the same active ingredient as Ozempic, but approved for weight loss. Tirzepatide is a different drug sold as Mounjaro and Zepbound.